|
WO2020150369A1
|
|
Hiv-1 protease inhibitors and uses thereof
|
|
US2020207746A1
|
|
Herboxidiene derivatives and uses thereof
|
|
US2020165264A1
|
|
Macrocyclic hiv-1 protease inhibitors and uses thereof
|
|
WO2015175994A1
|
|
Hiv-1 protease inhibitors and uses thereof
|
|
US2014148508A1
|
|
C-3 substituted bicyclooctane based HIV protease inhibitors
|
|
WO2012092188A1
|
|
Hydrogen bond forming p1 ligands and methods for treating hiv
|
|
US2013338380A1
|
|
Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans
|
|
US2012059161A1
|
|
Compounds and methods for treating AIDS and HIV infections
|
|
US2011230505A1
|
|
Quinazoline inhibitors of BACE 1 and methods of using
|
|
US2011118330A1
|
|
HIV protease inhibitors and methods for using
|
|
WO02053594A2
|
|
Inhibitors of memapsin 2 and use thereof
|
